Pediatric Extracorporeal Membrane Oxygenation Anticoagulation Protocol Associated with a Decrease in Complications
| Autor: | Mary F Weeks, Carrie F Garrison, Sarah W Tramel, Christopher L Jenks, Lily M Landry, Joshua G Campbell, Jarrod D. Knudson |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_treatment
Biomedical Engineering Biophysics Bioengineering Pediatrics Biomaterials Fibrinogen levels Extracorporeal Membrane Oxygenation Renal injury Blood product Coagulopathy medicine Extracorporeal membrane oxygenation Humans Platelet Child Retrospective Studies business.industry Heparin Incidence (epidemiology) Anticoagulants General Medicine medicine.disease Anesthesia Cryoprecipitate business |
| Zdroj: | ASAIO journal (American Society for Artificial Internal Organs : 1992). 68(2) |
| ISSN: | 1538-943X |
| Popis: | Extracorporeal membrane oxygenation (ECMO) in pediatrics has rapidly progressed in recent years; however, there continues to be considerable variation in anticoagulation practices. In 2016, we implemented a standardized anticoagulation protocol in effort to reduce clotting and bleeding complications. A single-center retrospective analysis of pediatric patients requiring ECMO between 2014 and 2018 was performed. One hundred one ECMO cases in 94 pediatric patients met eligibility criteria (preprotocol = 64 cases; postprotocol = 37 cases). Demographics, ECMO parameters, complications, laboratories, and blood product requirements were analyzed for differences between the two groups. There was a significant decrease in the incidence of hematologic (p < 0.022), neurologic (p < 0.001), and renal complications (p < 0.001) in the postprotocol era. Incidence of bleeding, cardiac/pulmonary complications, and circuit changes were similar between the groups. The postprotocol group required fewer transfusions of red blood cells and cryoprecipitate. Additionally, platelet counts and fibrinogen levels were maintained higher in the postprotocol era. In conclusion, implementation of a standardized anticoagulation protocol was associated with improved anticoagulation parameters and a decrease in hematologic and neurologic complications, coagulopathy, renal injury, and blood product administration. We attribute these findings to transitioning to anti-Xa as a measure of heparinization and maintaining higher platelet counts. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|